1BMT cluster

1

PharM clusTers in leading counTries

UK11 largest clusters

Russia7 largest clusters

Germany28 largest clusters

USA15 largest clusters

France18 largest clusters

Japan28 largest clusters

Netherlands5 largest clusters

2

gloBal MarkeTs. BioMedical Technologies

Compound Annual Growth Rate (till 2020)

Market volume

The main segments

2011

2015

2020

clinical medicine and healthcare

Biomedical and life science

Bio-informatics

Industrial bio-techInternational

russian

International

russian

320$ bn

750$ bn

3$ bn

14$ bn

8%14%

133,8 $ bn

264 $ bn

76 $ bn

2,7 $ bn

3

key acTiviTies

To build the viable and self-regulating ecosystem, favorable for business• To attract innovative companies for Skolkovo participation

• Create and support international expert panel

• Financial support for the Participants

• Attract investors

• Create and support infrastructure(Centers of shared facilities (CSF) and Centers of applied research(CAR)

• Support educational platforms

4

key eleMenTs of The ecosysTeM

ecOsystem

educational environment

Regulatory environment

Institutes of commerciali-

zation

clustercommunity

Infrastructures

4

3

2

1

32

1

54

5

•Educationalprograms(openlectures)•Foresightseminars•Internships•Conferences

•CentersforSharedFacilities(CSF)•CentersofAppliedResearch(CAR)•R&Dcenters.Keypartners

•residents•investors•universities•ministries•regionalclusters•expertpanel

•Businessincubators•Venturecapitalfunds•Strategicindustrialinvestors•Institutionalpartners

•Seminarsforresidents (tax,legal,customs,IP, project wrapping consultations)

5

clusTer sTraTegy

companies

Infrastructures

2011 2012 2013 2014

ResIdents

GRants (mln)

csF/caR

R & d centeRs wIth key paRtneRs

2 5

1

8

3

100

$53

150

$90

200

$300

cO-Investments (mln) $21 $36 $120

6

ProjecTs. resulTs 2010-2011

OutsIde Investments

mInI-GRants

GRants

FIRst tRanchs

87

$ 76 mln

$ 32 mln

$ 49 mln

$ 0,15 mln

appr

oved

quan

tity

th

e to

tal

amou

nt

the

tota

l am

oun

tth

e to

tal

amou

nt

RESIDENTS

15 PaRTIcIPaNTS

7

ImagINg

Planned csf/car

PRE-clINIcal RESEaRch. glP STaNDaRDS

REgENERaTIvE mEDIcINE aND cEll TEchNology

SySTEm bIoINfoRmaTIcS

STRucTuRal bIology. mEmbRaNE PRoTEIN aND ThEIR comPlExES

PRoTEomIcS aND mETabolomIocS

NuclEaR mEDIcINE

SyNThETIc bIology

cSf/caR

8

foresighTs of clusTer BMT

•Newhealthcaremethods and technologies targeting the «big killers“

•Personalizedmedicine

•Preventivemedicine

•ITinClinicalMedicine

•Medicalequipment,devices, implants and materials

•NuclearMedicine

•Highthroughputdataanalysis

•Computeraideddrugdesign

•Imageanalysis

•Systemsbiology

•Bio-remediationandbio-degradation

•Ecology

•Industrialdrug-productiontechnologies\

•foodsecurity

•Novelpharmaceuticals

•Newdrugdeliverysystems

•Newtargetsfortreatment

•Pre-clinincaldevelopment and trials

•Moleculardiagnostics

clInIcal medIcIne and healthcaRe BIO-InFORmatIcs

BIOmedIcal and lIFe scIencesw

IndustRIal BIO-tech

9

MInIstry and prIvate Investors

“skolkovo” unIversIty BIoMedIcal faculty

russIan partners: the unIversItIes and he r&d centers

foreIgn unIversIty partners

educaTional environMenT

OPEN lECTuRES

SEMINARSPOSTSATRuSSIANWIKIPEDIA

CONFERENCES

10

ParTners

INVESTORS PARTNERS

R&DCENTERS. KEyPARTNERSR&D

CENTERS. KEyPARTNERS

REIONAlPARTNERSVENTuREFuNDS

PRIVATEINVESTORS ANDBANKS

BIgPHARMCOMPANIES

gOVERMENTORgANIzATIONS

FOREIgNPARTNERS

11

DIRECTORFOREDuCATIONANDSCIENCE

Janssen chRIs

DIRECTORFORINVESTMSNTSANDDEVElOPMENT

kOmOlOv andRey

clusTer BMT (2012)

CluSTER ExECuTIVEDIRECTOR

GORyanIn IGOR

Contacts:kolomenskaya polina

kazbekova victoria

Krasnopresnenskayanaberezhnaya,12, Entrance№9,Floor24, Moscow,123610

Тел.:+7(495)9670148(ex.2114/2364) Факс:+7(495)9670196

e-mail:cluster-bmt@sk.ru www.sk.ru